Chloroquine (CQ) was used with AP/ES (anti-EGFR Aptamers- modified polyamidoamine) to restore tumor vasculature to provide optimal drug/gene delivery and overcome treatment resistance in NSCLC cells. Here, EGFR is linked to neoplasm.